Compare CRMN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRMN | AEON |
|---|---|---|
| Founded | 2024 | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0M | 13.0M |
| IPO Year | 2024 | 2021 |
| Metric | CRMN | AEON |
|---|---|---|
| Price | $1.01 | $0.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $1.82 |
| AVG Volume (30 Days) | ★ 1.1M | 608.0K |
| Earning Date | N/A | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $0.13 |
| 52 Week High | $0.82 | $1.45 |
| Indicator | CRMN | AEON |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 27.24 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $0.33 |
| Average True Range (ATR) | 0.00 | 0.03 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 7.80 |
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.